Esmolol to Treat the Hemodynamic Effects of Septic Shock
NCT02369900 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2021-06-28
Summary
The main purpose of this study is to determine the effects of controlling the heart rate of patients with septic shock using an intravenous medication called esmolol.
Conditions
- Septic Shock
- Hypotension
- Tachycardia
Interventions
- DRUG
-
Esmolol
- OTHER
-
Saline
Sponsors & Collaborators
- collaborator OTHER
-
Beth Israel Deaconess Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Esmolol Effects on Heart and Inflammation in Septic Shock
NCT02068287 ·Status: UNKNOWN ·Phase: PHASE2
-
Pilot Study: Echocardiographic and Hemodynamic Effects of Esmolol in Septic Shock Patients
NCT02842983 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Effect of a Continuous Infusion of Esmolol on Stroke Volume in Patients With Hyperdynamic Vasoplegic Septic Shock
NCT02609152 ·Status: WITHDRAWN ·Phase: PHASE3
-
Esmolol to Control Adrenergic Storm in Septic Shock- ROLL-IN 2
NCT03208257 ·Status: UNKNOWN ·Phase: PHASE2
-
Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes
NCT06390748 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Esmolol on Patients With Sepsis
NCT04537767 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dexmedetomidine vs Esmolol or Placebo on Cerebral Hemodynamics in Septic Shock
NCT06169475 ·Status: COMPLETED ·Phase: NA
-
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
NCT04748796 ·Status: RECRUITING ·Phase: PHASE3
-
Protocol-driven Hemodynamic Support for Patients With Septic Shock
NCT00335907 ·Status: UNKNOWN ·Phase: NA
-
Phenylephrine Versus Norepinephrine for Septic Shock in Critically Ill Patients
NCT02203630 ·Status: TERMINATED ·Phase: PHASE4
-
Echocardiography in Septic Shock
NCT02135796 ·Status: UNKNOWN
-
Place of Echocardiography in IV Fluid Therapy in Patients With Septic Shock and Left Ventricular Systolic Dysfunction
NCT02899897 ·Status: COMPLETED
-
Midodrine Use in Septic Shock
NCT03706053 ·Status: TERMINATED ·Phase: PHASE3
-
POCUS-Guided Esmolol in Septic Shock: A Pilot RCT
NCT07313605 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Study of the Role of Interferon αon the Endothelial Dysfunction During Septic Shock
NCT04204694 ·Status: UNKNOWN
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis
NCT02576457 ·Status: TERMINATED ·Phase: PHASE1
-
Balanced Salt Solution VS. Normal Saline Solution in Septic Shock
NCT02336620 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Metoprolol in Septic Shock
NCT06592547 ·Status: COMPLETED ·Phase: PHASE2
-
Angiotensin II vs. Vasopressin in Septic Shock
NCT05193370 ·Status: WITHDRAWN ·Phase: PHASE4
-
Ventriculo-arterial Coupling and Myocardial Work in Sepsis and Septic Shock
NCT06853574 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Resuscitation With Plasma in Surgical and Trauma Patients With Septic Shock
NCT03366220 ·Status: TERMINATED ·Phase: PHASE2
-
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Global Longitudinal Strain Assessment in Cardiogenic Shock During Sepsis
NCT04141410 ·Status: UNKNOWN
-
Modulation of Vasoreactivity in Septic Shock: Impact of Recombinant Protein C
NCT02885168 ·Status: COMPLETED ·Phase: PHASE4